Clinical trials recruiting in Osaka, Sakai, Japan
3
Recruiting trials
6
Conditions
Phase breakdown
Phase 2 2Phase 3 1
Conditions recruiting in Osaka, Sakai, Japan
| Condition | Trials |
|---|---|
| Lung cancer | 3 |
| Extra-pulmonary Neuroendocrine Carcinoma | 1 |
| Lung Cancer, Non-squamous, Non-small Cell | 1 |
| Neuroendocrine Neoplasms | 1 |
| Non-small Cell Lung Cancer | 1 |
| Small Cell Lung Carcinoma | 1 |
Recruiting trials in Osaka, Sakai, Japan
- Beamion 44: A Study to Test How Well Zongertinib is Tolerated by People With Advanced Non-small Cell Lung Cancer With HER2 Mutations When Given in Combination With Chemotherapy With or Without Pembrolizumab
- Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
- DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
Common questions
How many clinical trials are recruiting in Osaka, Sakai, Japan?
3 recruiting trials have at least one study site in Osaka, Sakai, Japan.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.